| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |